Screener
Eli Lilly LLY Q3 2026 earnings
Reported October 29, 2026 · Before market open
Revenue$24.4BBeat by $1.8B
Adjusted EPS$7.48Beat by $1.80
Revenue estimate$22.6B
EPS estimate$5.68
“Lilly had another strong quarter, exceeding our prior expectations and allowing us to raise our full-year outlook”
Next report
Oct 29, 2026 (Today)Revenue estimate$22.6B
EPS estimate$5.68
Valuation & ratios
Segments
Versus estimates
Revenue
FAQ
- When did Eli Lilly report Q3 2026 earnings?
- Eli Lilly (LLY) reported Q3 2026 earnings on October 29, 2026 before market open.
- What were Eli Lilly's Q3 2026 revenue and EPS?
- Eli Lilly reported revenue of $24.4B and adjusted eps of $7.48 for Q3 2026.
- Did Eli Lilly beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $22.6B by $1.8B. EPS beat the consensus estimate of $5.68 by $1.80.
- How did Eli Lilly's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 38.6% from $17.6B a year earlier.
- Where can I find Eli Lilly's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0000059478-26-000104) and the 10-Q periodic report (0000059478-26-000108) directly on SEC EDGAR. The filing index links above go to sec.gov.
